Literature DB >> 12035774

Sexual behaviour, STDs and drug use in a crack house population.

M W Ross1, L Y Hwang, L Leonard, M Teng, L Duncan.   

Abstract

We aimed to investigate the prevalence of ulcerative sexually transmissible diseases (STDs) and hepatitis in crack users. We interviewed 435 crack users on site in crack houses in Houston, Texas and took blood for laboratory analysis. There was evidence of syphilis infection in 13%, herpes simplex virus-2 (HSV-2) in 61%, HIV in 12%, hepatitis B in 52%, and hepatitis C in 41% of cases. On DSM-III-R criteria, 12% were crack abusers and 84% crack dependent: over half reported previous treatment. Forty per cent reported also injecting. Sexual behaviour indicated a mean of 2.4 partners in the past month for men, 3.7 for women. Sexual behaviour was largely vaginal, although women also reported more than twice the level of oral sex of men. Significant multivariate predictors for HIV and hepatitis B and C were previous reported STD and injecting drug use (including sharing needles), while female gender for syphilis and HSV-2, and additionally condom use for HSV-2, were significant risks. These data confirm high rates of STDs in a crack house population as inferred from previous clinic-based and community studies, and the link between STDs, injecting and HIV. The high rates of STDs found should lead to considering STDs and substance abuse to be dual diagnoses in crack users and the integration of STD diagnosis and treatment into crack outreach and treatment programmes.

Entities:  

Mesh:

Year:  1999        PMID: 12035774     DOI: 10.1258/0956462991913989

Source DB:  PubMed          Journal:  Int J STD AIDS        ISSN: 0956-4624            Impact factor:   1.359


  18 in total

1.  Crack use as a public health problem in Canada: call for an evaluation of 'safer crack use kits'.

Authors:  Emma Haydon; Benedikt Fischer
Journal:  Can J Public Health       Date:  2005 May-Jun

Review 2.  Behavior change and health-related interventions for heterosexual risk reduction among drug users.

Authors:  Salaam Semaan; Don C Des Jarlais; Rob Malow
Journal:  Subst Use Misuse       Date:  2006       Impact factor: 2.164

3.  Risk factors in the relationship between gender and crack/cocaine.

Authors:  C W Lejuez; Marina A Bornovalova; Elizabeth K Reynolds; Stacey B Daughters; John J Curtin
Journal:  Exp Clin Psychopharmacol       Date:  2007-04       Impact factor: 3.157

4.  Screening for sexually transmitted infections in substance abuse treatment programs.

Authors:  Jane M Liebschutz; Erin P Finley; Phillip G Braslins; Demian Christiansen; Nicholas J Horton; Jeffrey H Samet
Journal:  Drug Alcohol Depend       Date:  2003-05-01       Impact factor: 4.492

5.  Correlates of exchange sex among a population-based sample of low-income women who have heterosexual sex in Baltimore.

Authors:  Susan G Sherman; Marisa Hast; Ju Nyeong Park; Michele R Decker; Colin Flynn; Danielle German
Journal:  AIDS Care       Date:  2018-03-08

6.  Herpes simplex virus 2 and syphilis among young drug users in Baltimore, Maryland.

Authors:  S S Plitt; S G Sherman; S A Strathdee; T E Taha
Journal:  Sex Transm Infect       Date:  2005-06       Impact factor: 3.519

7.  Correlates to seroprevalent herpes simplex virus type 2 among rural Appalachian drug users.

Authors:  Dustin B Stephens; April M Young; Ursula L Mullins; Jennifer R Havens
Journal:  J Med Virol       Date:  2015-08-27       Impact factor: 2.327

8.  Sexual HIV/HSV-2 risk among drug users in New York City: an HIV testing and counseling intervention.

Authors:  Marlene Pantin; Noelle R Leonard; Holly Hagan
Journal:  Subst Use Misuse       Date:  2013-03-25       Impact factor: 2.164

9.  Personal and partner measures in stages of consistent condom use among African-American heterosexual crack cocaine smokers.

Authors:  U E Pallonen; M L Williams; S C Timpson; A Bowen; M W Ross
Journal:  AIDS Care       Date:  2008-02

10.  Efficacy of a woman-focused intervention to reduce HIV risk and increase self-sufficiency among African American crack abusers.

Authors:  Wendee M Wechsberg; Wendy K K Lam; William A Zule; Georgiy Bobashev
Journal:  Am J Public Health       Date:  2004-07       Impact factor: 9.308

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.